Denette Lamb, APRN
Adult Health · Hutchinson, KSNPI 1336404524
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,634 of the $2,527 with a category attached, or 64.6%. 22 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 34.4% of the total. 2024 is the largest year on record at $1,466, more than ten times the $136 reported in 2021.
Across 71 payments — averaging $35.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$870
- AstraZeneca$517
- Mylan Specialty L.p.$127
- Sanofi$123
- Axsome Therapeutics, Inc.$123
- Grifols USA, LLC$116
- plus $652 from 16 others
What the payments were for
- Travel & lodging$83633%
- Food & beverage$1,63465%
- Education$572%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 3 | $870 |
| AstraZeneca | 17 | $517 |
| Mylan Specialty L.p. | 7 | $127 |
| Sanofi | 5 | $123 |
| Axsome Therapeutics, Inc. | 2 | $123 |
| Grifols USA, LLC | 5 | $116 |
| Boehringer Ingelheim | 4 | $104 |
| AbbVie | 3 | $75 |
| Regeneron Healthcare Solutions, Inc. | 4 | $62 |
| United Therapeutics Corporation | 3 | $60 |
| Sanofi-aventis U.S. LLC | 1 | $57 |
| GSK | 3 | $53 |
| Actelion Pharmaceuticals US, Inc. | 3 | $47 |
| Paratek Pharmaceuticals, Inc. | 2 | $30 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $24 |
| Electromed, Inc. | 2 | $21 |
| Amgen | 1 | $21 |
| Merck | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Novartis | 1 | $19 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,527 in reported general payments places this provider in the 80th percentile of 155 adult health providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $15,437 |
| Spiriva HandihalerTiotropium Bromide | 18 | $11,070 |
| Breo ElliptaFluticasone/Vilanterol | 22 | $7,367 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 26 | $5,669 |
| Arnuity ElliptaFluticasone Furoate | 19 | $4,879 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 66 | $2,298 |
| Azithromycin | 12 | $152 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 15 | $97 |
| Montelukast Sodium | 18 | $96 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $53 | $27,68360 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 155 adult health providers in Kansas.
Other adult health in Hutchinson
- Valerie DavisWichita$100K
- Julianna BergkampWichita$18K
- Lauren FieldsOverland Park$12K
- Tina LegaultOverland Park$12K
- Candace KoirthPratt$11K
- Jennifer SurpriseKansas City$8K
- Angela leWichita$7K
- Monica PfeifferOverland Park$7K
- Amy RiederOverland Park$6K
- Jenny PearsonKansas City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.